Armata Pharmaceuticals, Inc. Income Statement
ARMP|1 years of annual SEC 10-K data (FY2014-FY2014)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data. All figures from audited SEC 10-K filings.
Armata Pharmaceuticals, Inc. reported $409,000 in revenue and $23M in net income for FY2014. Its profit margin was 5650.1% in FY2014.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -12.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2014 |
|---|---|
| Revenue | $409.0K |
| SG&A Expense | $6.8M |
| R&D Expense | $5.8M |
| Operating Income | -$14.1M |
| Interest Expense | $0 |
| Net Income | $23.1M |
| EPS (Basic) | -$0.64 |
| EPS (Diluted) | -$0.64 |
| Shares Outstanding | 182.5M |
| Operating Margin | -3449.9% |
| Profit Margin | 5650.1% |